Specific genetic factors may lead to negative response to AREDS formulation

FLORENCE, Italy — High-dose zinc, as in the AREDS and AREDS2 formulations, may be harmful in patients with high complement factor H and low age-related maculopathy susceptibility 2 risk alleles, according to one speaker. “There is considerable evidence that response to AREDS supplements is influenced by genetic risk,” Carl C. Awh, MD, said at the FLOREtina meeting.

Full Story →